Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT1061260004Recruiting
Randomised, open-label trial of elobixibat in chronic constipation (2 arms). Primary endpoint: Total volume of Moviprep and water consumed until completion of bowel preparation. Started May 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT1061260004.